PharmAla will be the sole provider of both GMP and Engineering MDMA to Awakn VANCOUVER, BC — PharmAla Biotech Holdings Inc. (“PharmAla”)(CSE: MDMA), a biotechnology company focused on the research,… Read More
Ontario joins Quebec, Alberta and Saskatchewan to fund gene-based treatment for previously untreatable genetic retinal conditions1 Luxturna® is the first and only pharmacological treatment for an inherited retinal disease designed to help improve functional vision in patients… Read More
Arrival of PrBYOOVIZ™ provides new, sustainable treatment option for Canadians with serious eye disorders that can lead to irreversible vision loss BYOOVIZ brings biosimilar science and the recognized efficacy of reference… Read More
OTTAWA, ON — Canada’s universal, accessible and publicly funded healthcare is a point of pride for Canadians. However, health workers across Canada are under enormous strain to deliver the care… Read More
VICTORIA, BC — Budget 2023 invests in improving health and mental-health care, creating more affordable housing, growing a clean economy and delivering more help with costs – especially for families… Read More
